gip and glp-1 agonist EASD 2018: benefits of GIP/GLP-1 receptor co-agonists in T2D GI Adverse Effects of Glucagon-Like

53.2 Metabolism and cytotoxicity

These include how bad the B12 deficiency is, any health issues, and how well the body responds to the treatment

firstly demonstrates the utility of a novel metabolic agent, GLP-1, in attenuating myocardial stunning after ischemiareperfusion in canine models [97]

Patients on both medications should maintain consistent timing, avoid calcium and iron supplements near thyroid medication, and communicate with their provider if gastrointestinal symptoms (nausea, constipation) worsen

[DOI] [PubMed] [Google Scholar] 101.Tsukamoto H, Lin M, Ohata M, Giulivi C, French SW, Brittenham G

[1] OConnor JE, et al, 1990: New roles of Carnitine metabolism in ammonia cytotoxicity